Congenital Long QT Syndrome (LQTS)

Cardiology (Genetics)

Overview

Definition

A disorder of myocardial repolarization characterized by a prolonged QT interval on ECG and an increased risk of Torsades de Pointes.

Epidemiology

Estimated prevalence of 1 in 2,000. Often a cause of unexplained sudden death in the young.

Etiology & Risk Factors

  • Mutations in cardiac potassium (KCNQ1, KCNH2) or sodium (SCN5A) channels
  • Romano-Ward syndrome (autosomal dominant, purely cardiac)
  • Jervell and Lange-Nielsen syndrome (autosomal recessive, associated with sensorineural deafness)

Clinical Symptoms

  • Syncope (often triggered by emotional stress, sudden loud noises, or swimming depending on the subtype)
  • Seizures (frequently misdiagnosed)
  • Sudden cardiac arrest

Clinical Approach

Diagnosis

  • ECG: QTc interval > 470 ms (males) or > 480 ms (females)
  • Genetic testing for risk stratification

Management

  • Beta-blockers (Nadolol or Propranolol) are first-line to blunt the sympathetic response
  • Avoid QT-prolonging drugs (e.g., Macrolides, Fluoroquinolones, Antipsychotics, Ondansetron)
  • ICD placement for high-risk patients (prior arrest, syncope despite beta-blockers)
  • Left cardiac sympathetic denervation (LCSD)

Complications

  • Torsades de Pointes (Polymorphic V-Tach)
  • Sudden Cardiac Death